Abstract
Spectrins play a pivotal role in axonal transport, neurite extension, the organization of synaptic vesicles, as well as for protein sorting in the Golgi apparatus and cell membrane. Among spectrins there is great variability in sequence composition, tissue distribution, and function, with two known genes encoding the α-chain, and at least five encoding the β-chain. It remains unclear as to whether novel β-spectrins such as elf1-4are distinct genes or β-G-spectrin isoforms. The role for ELF in the developing nervous system has not been identified to date. In this study we demonstrate the genomic structure of elf-3, as well as the expression of ELF in the developing mouse brain using a peptide specific antibody against its distinctive amino-terminal end. Full genomic structural analyses reveal that elf-3is composed of 31 exons spanning ∼67˜kb, and confirm that elfand mouse brain β-G-spectrin share multiple exons, with a complex form of exon/intron usage. In embryonic stages, E9–12, anti-ELF localized to the primary brain vesicular cells that also labeled strongly with anti-nestin but not anti-vimentin. At E12–14, anti-ELF localized to axonal sprouts in the developing neuroblasts of cortex and purkinje cell layer of the cerebellum, as well as in cell bodies in the diencephalon and metencephalon. Double labeling identified significant co-localization of anti-ELF, nestin and dystrophin in sub ventricular zone cells and in stellate-like cells of the developing forebrain. These studies define clearly the expression of ELF, a new isoform of β-G-spectrin in the developing brain. Based on its expression pattern, ELF may have a role in neural stem cell development and is a marker of axonal sprouting in mid stages of embryonic development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Altschul SF, Gish W . 1996 Methods Enzymol. 266: 460–480
Altschul SF, Madden TI, Schaffer AA, Zhang J, Miller W, Lipman DJ . 1997 Nucleic Acids Res. 25: 3389–3402
Beck KA, Nelson WJ . 1998 Biochem. Biophys. Acta 1404: 153–160
Bennett V, Davis J, Fowler WE . 1982 Nature 299: 126–131
Bennett V, Gilligan DM . 1993 Annu. Rev. Cell. Biol. 9: 27–66
Birkenmeier CS, McFarland-Starr EC, Barker JE . 1988 Proc. Natl. Acad. Sci. USA 85: 8121–8125
Black JD, Koury ST, Bankert RB, Repasky EA . 1988 J. Cell Biol. 106: 97–109
Blakeslee D . 1977 J. Immunol. Methods 17: 361–364
Bloch RJ, Morrow JS . 1989 J. Cell Biol. 108: 481–493
Bloom ML, Birkenmeier CS, Barker JE . 1993 Blood 82: 2906–2914
Bulfield G, Siller WG, Wight PA, Moore KJ . 1984 Proc. Natl. Acad. Sci. USA 81: 1189–1192
Chen Y, Yu P, Lu D, Tagle DA, Cai T . 2001 J. Mol. Neurosci. 17: 59–70
Craig SW, Pardo JV . 1983 Cell Motil. 3: 449–462
Dahlstrand J, Lardelli M, Lendahl U . 1995 Brain Res. Dev. Brain Res. 84: 109–129
Davis J, Bennett V . 1983 J. Biol. Chem. 258: 7757–7766
De Matteis MA, Morrow JS . 2000 J. Cell. Sci. 113: 2331–2343
Devarajan P, Morrow JS . 1996 Membrane Protein-Cytoskeleton Complexes; Protein Interactions, Distributions and Functions Vol. 43: Nelson WJ (ed) New York: Academic Press pp. 97–128
Devarajan P, Stabach PR, De Matteis MA, Morrow JS . 1997 Proc. Natl. Acad. Sci. USA 94: 10711–10716
Devarajan P, Stabach PR, Mann AS, Ardito T, Kashgarian M, Morrow JS . 1996 J. Cell Biol. 133: 819–830
Doetsch F, Garcia-Verdugo JM, Alvarez-Buylla A . 1997 J. Neurosci. 17: 5046–5061
Dubowitz V, Crome L . 1969 Brain 92: 805–808
Dubreuil RR, Wang P, Dahl S, Lee J, Goldstein LS . 2000 J. Cell Biol. 149: 647–656
Emery AH (ed) . 1988 Duchenne Muscular Dystrophy New York: Oxford University Press
Fath KR, Trimbur GM, Burgess DR . 1997 J. Cell Biol 139: 1169–1181
Gallagher PG, Forget BG . 1993 Semin. Hematol. 30: 4–20
Gallagher PG, Sabatino DE, Romana M, Cline AP, Garrett LJ, Bodine DM, Forget BG . 1999 J. Biol. Chem. 274: 6062–6073
Gallagher PG, Tse WT, Scarpa AL, Lux SE, Forget BG . 1997 J. Biol. Chem. 272: 19220–19228
Glenney Jr JR, Glenney P, Weber K . 1983 J. Cell Biol. 96: 1491–1496
Goodman SR, Zimmer WE, Clark MB, Zagon IS, Barker JE, Bloom ML . 1995 Brain Res. Bull. 36: 593–606
Hammarlund M, Davis WS, Jorgensena EM . 2000 J. Cell Biol. 149: 931–942
Hayes NV, Scott C, Heerkens E, Ohanian V, Maggs AM, Pinder JC, Kordeli E, Baines AJ . 2000 J. Cell Sci. 113: 2023–2034
Hu RJ, Moorthy S, Bennett V . 1995 J. Cell Biol. 128: 1069–1080
Hu RJ, Watanabe M, Bennett V . 1992 J. Biol. Chem. 267: 18715–18722
Joosten EA, Gribnau AA . 1989 Neuroscience 31: 439–452
Jung D, Pons F, Leger JJ, Aunis D, Rendon A . 1991 Neurosci. Lett. 124: 87–91
Kadonaga JT, Tjian R . 1986 Proc. Natl. Acad. Sci. USA 83: 5889–5893
Kageyama R, Pastan I . 1989 Cell 59: 815–825
Kordeli E, Davis J, Trapp B, Bennett V . 1990 J. Cell Biol. 110: 1341–1352
Kordeli E, Lambert S, Bennett V . 1995 J. Biol. Chem. 270: 2352–2359
Kunimoto M, Adachi T, Ishido M . 1998 J. Neurochem. 71: 2585–9252
Leid M, Kastner P, Chambon P . 1992 Trends Biochem. Sci. 17: 427–433
Levine J, Willard M . 1981 J. Cell Biol. 90: 631–642
Lidov HG, Byers TJ, Watkins SC, Kunkel LM . 1990 Nature 348: 725–728
Lux SE, Palek J . 1995 Blood. Handin RI, Lambert S and Stossel TP (ed) Philadelphia: JB Lippincott pp. 1701–1816
Ma Y, Zimmer WE, Riederer BM, Bloom ML, Barker JE, Goodman SR . 1993 Mol. Brain Res. 18: 87–99
Malchiodi-Albedi F, Ceccarini M, Winkelmann JC, Morrow JS, Petruci TC . 1993 J. Cell Sci. 106: 67–78
Marin-Padilla M . 1985 J. Comp. Neurol. 235: 82–96
Mishra L, Cai T, Levine A, Weng D, Mezey E, Mishra B, Gearhart J . 1998 Int. J. Dev. Biol. 42: 221–224
Mishra L, Cai T, Yu P, Monga SP, Mishra B . 1999 Oncogene 18: 353–364
Mishra L, Tully RE, Monga SP, Yu P, Cai T, Makalowski W, Mezey E, Pavan WJ, Mishra B . 1997 Oncogene 15: 2361–2368
Moon RT, McMahon AP . 1987 Bioessays 7: 159–164
Moorthy S, Chen L, Bennett V . 2000 J. Cell Biol. 149: 915–930
Morrow JS, Rimm DL, Kennedy SP, Ciancia CD, Sinard JH, Weed SA . 1997 Handbook of Physiology. Jamieson J (ed) Oxford: Oxford University Press pp. 485–540
Nelson WJ, Hammerton RW . 1989 J. Cell Biol. 108: 893–902
Nelson WJ, Veshnock PJ . 1987a J. Cell Biol. 104: 1527–1537
Nelson WJ, Veshnock PJ . 1987b Nature 328: 533–536
Ohara O, Ohara R, Yamakawa H, Nakajima D, Nakayama M . 1998 Brain Res. Mol. Brain Res. 57: 181–192
Pinder JC, Baines AJ . 2000 Nature 406: 253–254
Riederer BM, Zagon IS, Goodman SR . 1986 J. Cell Biol. 102: 2088–2097
Roesler WJ, Vandenbark GR, Hanson RW . 1989 J. Biol. Chem. 264: 9657–9664
Sakaguchi G, Orita S, Naito A, Maeda M, Igarashi H, Sasaki T, Takal Y . 1998 Biochem. Biophys. Res. Commun. 248: 846–851
Sambrook J, Fritsch EF, Manlatis T (ed) . 1989 Molecular Cloning Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
Sanger F, Nicklen S, Coulson AR . 1977 Proc. Natl. Acad. Sci. USA 74: 5463–5467
Scotland P, Zhou D, Benveniste H, Bennett V . 1998 J. Cell Biol. 143: 1305–1315
Sihag RK, Shea TB, Wang F-S . 1996 J. Neurosci. Res. 44: 430–437
Sikorski AF, Sangerman J, Goodman SR, Critz SD . 2000 Brain Research 852: 161–166
Sikorski AF, Terlecki G, Zagon IS, Goodman SR . 1991 J. Cell Biol. 114: 313–318
Siman R, Ahdoot M, Lynch G . 1987 J. Neurosci. 7: 55–64
Sobue K . 1990 Neurosci. Res. 13: Suppl S80–S91
Sobue K, Kanda K . 1989 Neuron 3: 311–319
Srinivasan Y, Lewallen M, Angelides KJ . 1992 J. Biol. Chem. 267: 7483–7489
Stabach PR, Morrow JS . 2000 J. Biol. Chem. 275: 21385–21395
Stankewich MC, Tse WT, Peters LL, Ch'ng Y, John KM, Stabach PR, Devarajan P, Morrow JS, Lux SE . 1998 Proc. Natl. Acad. Sci. USA 95: 14158–14163
Takashima S, Becker LE, Armstrong DL, Chan F . 1981 Brain Res. 225: 1–21
Thomas G . 2000 Nat. Cell Biol. 2: E71–E72
Thomas GS, Kiehart DP . 1994 Development 120: 2039–2050
Wechsler A, Teichberg VI . 1998 EMBO J. 17: 3931–3939
Whittaker PA, Southern EM . 1986 Gene 41: 129–134
Winkelman JC, Leto TL, Watkins PC, Eddy R, Shows TB, Linnenbach AJ, Sahr KE, Kathuria N, Marchesi VT, Forget BG . 1988 Blood 72: 328–334
Yu P, Cai T, Monga SP, Mishra B, Mishra L . 1999 Mamm. Genome 10: 62–67
Zagon IS, Higbee R, Riederer BM, Goodman SR . 1986 J. Neurosci. 6: 2977–2986
Zarnescu DC, Thomas GH . 1999 J. Cell Biol. 146: 1075–1086
Zhou D, Lambert S, Malen PL, Carpenter S, Boland LM, Bennett V . 1998 J. Cell Biol. 143: 1295–1304
Ziemnicka-Kotula D, Xu J, Gu H, Potempska A, Kim KS, Jenkins EC, Trenkner E, Kotula L . 1998 J. Biol. Chem. 273: 13681–13692
Zimmer WE, Ma YP, Goodman SR . 1991 Brain Res. Bull. 27: 187–193
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tang, Y., Katuri, V., Iqbal, S. et al. ELF a β-spectrin is a neuronal precursor cell marker in developing mammalian brain; structure and organization of the elf/β-G spectrin gene. Oncogene 21, 5255–5267 (2002). https://doi.org/10.1038/sj.onc.1205548
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205548
Keywords
This article is cited by
-
Disruption of transforming growth factor-β signaling through β-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation
Oncogene (2007)
-
RING finger-dependent ubiquitination by PRAJA is dependent on TGF-β and potentially defines the functional status of the tumor suppressor ELF
Oncogene (2006)
-
TGF-β, Neuronal Stem Cells and Glioblastoma
Oncogene (2005)
-
Inactivation of ELF/TGF-β signaling in human gastrointestinal cancer
Oncogene (2005)